SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : EXTI - only public co. developing liver device
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: MaxLeverage who wrote (155)1/18/1998 6:52:00 PM
From: MaxLeverage  Read Replies (1) of 1063
 
Hello All,

Not that it's any great revelation, but I happened to notice that these two events took place on the same day.

From Exten:

1. August 4, 1997 Press Release- Dr. Considine appointed President of Xenogenics

From Loyola:

2. "Dr. John J. Brems, a transplant surgeon with expertise in general surgery and kidney and liver transplantation, joined Loyola's Department of Surgery on August 4, 1997."
meddean.luc.edu (this is the article where he talks about "development of an artificial liver.."

Note: as per previous post..both are the directors of Loyola's Liver Transplantation program.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News